Awards for “EXELAN PHARMACEUTICALS INC”
25 awards on this page · sorted by amount · page 2
| Award ID | Recipient | Awarding agency | Amount | Start | End | NAICS | Description |
|---|---|---|---|---|---|---|---|
| 36C26226N0307 | EXELAN PHARMACEUTICALS INC | Department of Veterans Affairs | $2.11M | 2026-01-15 | 2027-01-14 | 325412 | VA LOMA LINDA LENALIDOMIDE DO |
| 36C26226N0305 | EXELAN PHARMACEUTICALS INC | Department of Veterans Affairs | $2.07M | 2026-01-15 | 2027-01-14 | 325412 | VA ALBUQUERQUE LENALIDOMIDE DO |
| 36C25226P0110 | EXELAN PHARMACEUTICALS INC | Department of Veterans Affairs | $2M | 2025-12-15 | 2026-12-14 | 325412 | LENALIDOMIDE/REVLIMID DOSE |
| 36C24426N0401 | EXELAN PHARMACEUTICALS INC | Department of Veterans Affairs | $1.98M | 2026-02-06 | 2027-02-05 | 325412 | SPECIALTY PHARMACEUTICAL - LENALIDOMIDE |
| 36C26226N0310 | EXELAN PHARMACEUTICALS INC | Department of Veterans Affairs | $1.82M | 2026-01-15 | 2027-01-14 | 325412 | VA PRESCOTT LENALIDOMIDE DO |
| 36C24626N0406 | EXELAN PHARMACEUTICALS INC | Department of Veterans Affairs | $1.55M | 2026-01-15 | 2027-01-14 | 325412 | LENALIDOMIDE FOR THE HAMPTON VAMC FOR PATIENT CARE. |
| 36C24426N0404 | EXELAN PHARMACEUTICALS INC | Department of Veterans Affairs | $1.55M | 2026-02-06 | 2027-02-05 | 325412 | SPECIALTY PHARMACEUTICALS LENALIDOMIDE |
| 36C25226P0109 | EXELAN PHARMACEUTICALS INC | Department of Veterans Affairs | $1.5M | 2025-12-15 | 2026-12-31 | 325412 | LENALIDOMIDE/REVLIMID DOSE |
| 36C24426N0400 | EXELAN PHARMACEUTICALS INC | Department of Veterans Affairs | $1.49M | 2026-02-06 | 2027-02-05 | 325412 | SPECIALTY PHARMACEUTICAL - LENALIDOMIDE |
| 36C77020P0647 | EXELAN PHARMACEUTICALS INC | Department of Veterans Affairs | $1.4M | 2020-05-08 | 2020-05-18 | 325412 | AWARD 5 - ALBUTEROL - VA CMOP NATIONAL CONSOLIDATED ORDER |
| 36C25226P0149 | EXELAN PHARMACEUTICALS INC | Department of Veterans Affairs | $1.34M | 2026-01-16 | 2027-01-15 | 325412 | LENALIDOMIDE |
| 36C26326N0313 | EXELAN PHARMACEUTICALS INC | Department of Veterans Affairs | $1.32M | 2026-01-01 | 2026-12-31 | 325412 | GENERIC LENALIDOMIDE DRUG |
| 36C26026F0069 | EXELAN PHARMACEUTICALS INC | Department of Veterans Affairs | $1.28M | 2025-11-03 | 2026-09-30 | 325412 | PHARM - LENALIDOMIDE |
| 36C26326F0019 | EXELAN PHARMACEUTICALS INC | Department of Veterans Affairs | $1.21M | 2025-12-01 | 2026-09-30 | 325412 | LENALIDOMIDE CAPSULES |
| 36C24626N0421 | EXELAN PHARMACEUTICALS INC | Department of Veterans Affairs | $1.2M | 2026-01-15 | 2027-01-14 | 325412 | LENOLIDAMIDE FOR THE SALEM VAMC FOR PATIENT CARE |
| 36C26226N0306 | EXELAN PHARMACEUTICALS INC | Department of Veterans Affairs | $1.09M | 2026-01-15 | 2027-01-14 | 325412 | VA LONG BEACH LENALIDOMIDE DO |
| 36C24426N0397 | EXELAN PHARMACEUTICALS INC | Department of Veterans Affairs | $1.01M | 2026-02-06 | 2027-02-05 | 325412 | SPECIALTY PHARMACEUTICAL - LENALIDOMIDE |
| 36C25226P0105 | EXELAN PHARMACEUTICALS INC | Department of Veterans Affairs | $1M | 2025-12-15 | 2026-12-14 | 325412 | LENALIDOMIDE/REVLIMID DOSE |
| 36C26026F0261 | EXELAN PHARMACEUTICALS INC | Department of Veterans Affairs | $918.83K | 2026-06-01 | 2027-05-31 | 325412 | LENALIDOMIDE 5MG CAP,ORAL |
| 36C25726N0241 | EXELAN PHARMACEUTICALS INC | Department of Veterans Affairs | $899.35K | 2026-02-06 | 2027-02-05 | 325412 | LENALIDOMIDE ORAL MED |
| 36C26026F0169 | EXELAN PHARMACEUTICALS INC | Department of Veterans Affairs | $712.81K | 2026-04-01 | 2026-09-30 | 325412 | ORDER FOR LENALIDOMIDE CAPSULES. |
| 36C26026F0051 | EXELAN PHARMACEUTICALS INC | Department of Veterans Affairs | $712.81K | 2025-10-01 | 2026-03-31 | 325412 | PHARM - LENALIDOMIDE |
| 36C26326N0316 | EXELAN PHARMACEUTICALS INC | Department of Veterans Affairs | $702.55K | 2026-01-01 | 2026-09-30 | 325412 | GENERIC LENALIDOMIDE FOR CIVAHCS |
| 36C77020P0608 | EXELAN PHARMACEUTICALS INC | Department of Veterans Affairs | $700K | 2020-04-28 | 2020-05-08 | 325412 | Q0399 OPEN AND CONTINUOUS RFQ - AWARD 2 - EXELAN PHARMA |
| 36C77024P0006 | EXELAN PHARMACEUTICALS INC | Department of Veterans Affairs | $680.87K | 2023-10-03 | 2023-10-18 | 325412 | PHARMACEUTICALS |